Literature DB >> 1252177

Ocular toxoplasmosis in an adult receiving long-term corticosteroid therapy.

D H Nicholson, E B Wolchok.   

Abstract

Sudden death of a 58-year-old woman who developed ocular toxoplasmosis while receiving long-term systemic corticosteroid therapy permitted correlation of early histopathologic lesions with their clinical counterpart recorded on fundus photographs. A wide-spread, paravascular, whitish, retinal opacification dominated the initial clinical picture. These lesions were represented histologically by focal zones of inner retinal necrosis located adjacent to arteries and veins. No associated inflammatory cell infiltrate was present, and numerous viable free Toxoplasma organisms were consistently present at the interface between necrotic and healthy retina. Electron microscopy of formaldehyde-fixed tissue provided a useful technique for confirming the identity of the infecting organism in the absence of serologic or culture data.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1252177     DOI: 10.1001/archopht.1976.03910030120009

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  26 in total

1.  Toxoplasma gondii infection induces gene expression and secretion of interleukin 1 (IL-1), IL-6, granulocyte-macrophage colony-stimulating factor, and intercellular adhesion molecule 1 by human retinal pigment epithelial cells.

Authors:  C N Nagineni; B Detrick; J J Hooks
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

2.  Severe bilateral necrotising retinitis caused by Toxoplasma gondii in a patient with systemic lupus erythematosus and diabetes mellitus.

Authors:  J H Yamamoto; D I Boletti; Y Nakashima; C E Hirata; E Olivalves; M M Shinzato; T S Okay; R M Santo; M I S Duarte; J Kalil
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

3.  Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells.

Authors:  C N Nagineni; K Pardhasaradhi; M C Martins; B Detrick; J J Hooks
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

Review 4.  Ocular involvement in toxoplasmosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

5.  Simultaneous retinal and optic nerve lesions in toxoplasmosis: the advantages of magnetic resonance imaging.

Authors:  F X Borruat; R Kapoor; M D Sanders
Journal:  Br J Ophthalmol       Date:  1993-07       Impact factor: 4.638

6.  Focal electroretinogram and visual field defect in multiple evanescent white dot syndrome.

Authors:  M Horiguchi; Y Miyake; M Nakamura; Y Fujii
Journal:  Br J Ophthalmol       Date:  1993-07       Impact factor: 4.638

7.  Transforming growth factor-beta expression in human retinal pigment epithelial cells is enhanced by Toxoplasma gondii: a possible role in the immunopathogenesis of retinochoroiditis.

Authors:  C N Nagineni; B Detrick; J J Hooks
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

8.  Ocular toxoplasmosis in AIDS patients.

Authors:  D J Gagliuso; S A Teich; A H Friedman; J Orellana
Journal:  Trans Am Ophthalmol Soc       Date:  1990

Review 9.  Ocular toxoplasmosis II: clinical features, pathology and management.

Authors:  Nicholas J Butler; João M Furtado; Kevin L Winthrop; Justine R Smith
Journal:  Clin Exp Ophthalmol       Date:  2012-09-17       Impact factor: 4.207

10.  Bone-marrow transplantation and toxoplasmic retinochoroiditis.

Authors:  D Pauleikhoff; E Messmer; D W Beelen; M Foerster; A Wessing
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.